ArticleGynecologic oncology reports2022

Off-label use of paclitaxel and pembrolizumab in a case of platinum refractory epithelial ovarian cancer and extensive thromboembolism.

Clarissa Lam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.